Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 7Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Core Binding Factor Acute Myeloid Leukemia 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × OTHER × avapritinib × Clear all
NCT05821738 2023-05-09

Avapritinib in CBF-AML With KIT Mutations

The First Affiliated Hospital of Soochow University

Phase 2 Unknown
50 enrolled
MyeloidOther hematologic neoplasm

Core Binding Factor Acute Myeloid Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡